InsiderClue
Insiders · Profile

Mohindru Mani

Chief Executive Officer at Cardiff Oncology · CFO & Chief Strategy Officer at Tvardi Therapeutics. Filing since 17 Oct 2018. CIK 0001664708

CRDF Cardiff Oncology, Inc. Chief Executive Officer · 2 trades TVRD Tvardi Therapeutics, Inc. CFO & Chief Strategy Officer · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CRDF Cardiff Oncology, Inc.
14 Jul 2026
Chief Executive Officer
Bought
34,364
$50.00K
139%
CRDF Cardiff Oncology, Inc.
18 Jun 2026
Chief Executive Officer
Bought
24,703
$29.89K
opened
TVRD Tvardi Therapeutics, Inc.
4 Dec 2019
CFO & Chief Strategy Officer
Sold, plan not stated
4,755
$81.07K
21.4%
TVRD Tvardi Therapeutics, Inc.
15 Jul 2019
CFO & Chief Strategy Officer
Sold, plan not stated
37,431
$935.78K
73.0%
TVRD Tvardi Therapeutics, Inc.
29 May 2019
CFO & Chief Strategy Officer
Sold, plan not stated
2,496
$53.39K
15.3%
TVRD Tvardi Therapeutics, Inc.
13 Mar 2019
CFO & Chief Strategy Officer
Sold, plan not stated
16,041
$306.70K
66.7%
TVRD Tvardi Therapeutics, Inc.
28 Dec 2018
CFO & Chief Strategy Officer
Sold, plan not stated
4,500
$56.48K
35.9%
TVRD Tvardi Therapeutics, Inc.
15 Nov 2018
CFO & Chief Strategy Officer
Sold, plan not stated
16,042
$296.78K
100%
TVRD Tvardi Therapeutics, Inc.
17 Oct 2018
CFO & Chief Strategy Officer
Sold, plan not stated
16,042
$323.89K
100%
9 decisions on file.